Clinical Trials
2 trialsNCT07621484 2026-06-02
HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer
Shanghai Changzheng Hospital
Phase 2 Not yet recruiting
NCT07038629 2026-05-20
Chemoradiation Plus Iparomlimab Consolidation in Older With ESCC
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Recruiting